Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CervoMed (CRVO)
NASDAQ:CRVO
Holding CRVO?
Track your performance easily
CRVO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.28 - $26.38
Previous Close$15.8
Volume114.85K
Average Volume (3M)91.93K
Market Cap
$148.40M
Enterprise Value$85.32M
Total Cash (Recent Filing)$45.09M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.19
Next Earnings
Nov 11, 2024EPS Estimate
-$0.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.79
Shares Outstanding8,253,741
10 Day Avg. Volume103,109
30 Day Avg. Volume91,932
Standard Deviation0.35
R-Squared0.06
Alpha-0.00656
Financial Highlights & Ratios
Price to Book (P/B)2.61
Price to Sales (P/S)10.42
Price to Cash Flow (P/CF)-15.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.96
Enterprise Value/Gross Profit11.94
Enterprise Value/Ebitda177.86
Forecast
1Y Price Target
$57.60Price Target Upside220.36% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
CervoMed News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CRVO FAQ
What was CervoMed’s price range in the past 12 months?
CervoMed lowest stock price was $4.28 and its highest was $26.38 in the past 12 months.
What is CervoMed’s market cap?
Currently, no data Available
When is CervoMed’s upcoming earnings report date?
CervoMed’s upcoming earnings report date is Nov 11, 2024 which is in 53 days.
How were CervoMed’s earnings last quarter?
CervoMed released its earnings results on Aug 12, 2024. The company reported -$0.27 earnings per share for the quarter, beating the consensus estimate of -$0.306 by $0.036.
Is CervoMed overvalued?
According to Wall Street analysts CervoMed’s price is currently Undervalued.
Does CervoMed pay dividends?
CervoMed does not currently pay dividends.
What is CervoMed’s EPS estimate?
CervoMed’s EPS estimate is -$0.41.
How many shares outstanding does CervoMed have?
CervoMed has 8,253,741 shares outstanding.
What happened to CervoMed’s price movement after its last earnings report?
CervoMed reported an EPS of -$0.27 in its last earnings report, beating expectations of -$0.306. Following the earnings report the stock price went up 7.535%.
Which hedge fund is a major shareholder of CervoMed?
Among the largest hedge funds holding CervoMed’s share is RA Capital Management. It holds CervoMed’s shares valued at 14M.
---
CervoMed Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$57.60 (220.36% Upside)
$57.60 (220.36% Upside)
Hedge Fund Trend
Decreased
By 44.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $18.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.9%
Last 30 Days ▼ 2.4%
Last 30 Days ▼ 2.4%
Technicals
SMA
Positive
20 days / 200 days
Momentum
193.13%
12-Months-Change
Fundamentals
Return on Equity
-15.71%
Trailing 12-Months
Asset Growth
238.91%
Trailing 12-Months
Company Description
CervoMed
Diffusion Pharmaceuticals, Inc. is a clinical stage company which engages lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate, for use in those life threatening conditions in which cellular oxygen deprivation is the basis for significant unmet medical needs. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.
---
CRVO Stock 12 Month Forecast
Average Price Target
$57.60
▲(220.36% Upside)
Technical Analysis
ACADIA Pharmaceuticals
―
Aldeyra Therapeutics
―
EyePoint Pharmaceuticals
―
Kala Pharmaceuticals
―
Best Analysts Covering CRVO
1 Year
1 Year Success Rate
2/5 ratings generated profit
1 Year Average Return
-10.62%
reiterated a buy rating last month
Copying Sumant Kulkarni's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -10.62% per trade.
---